HOME >> MEDICINE >> NEWS
14-year study finds that quitting smoking adds years to life

PHILADELPHIA -- (Feb. 15, 2005) In a new study of 5,887 middle-aged smokers with mild lung disease, those who were randomly assigned to a quit-smoking program had a lower death rate than those assigned to usual care, even though only 21.7 percent of them actually quit smoking.

The annual death rates were 8.8 per 1000 participants in the quit-smoking program and 10.4 per 1000 in the usual care group. The annual death rates for those who actually quit was even more positive: 6.0 per 1000 patients compared with 11.0 per 1000 in those who did not quit smoking.

Overall, the death rate of those in both groups who were able to quit smoking was 46 percent lower than those who did not quit.

The study, "The Effects of a Smoking Cessation Intervention on 14.5-year Morality," is the first experimental study to show that stopping smoking adds years to life. It is published in the Feb. 15, 2005, issue of Annals of Internal Medicine.

The findings were based on data from the Lung Health Study. Randomized trials like the Lung Health Study are widely regarded as the gold standard for proof among clinical studies.

"We know that people who smoke should quit smoking," said one of the study authors, John E. Connett, PhD, professor of biostatistics of the University of Minnesota School of Public Health.

"This study showed that with very simple lung function tests -- spirometry -- we can find people who can benefit the most from an intensive quit-smoking program," Connet said. "And it not only made them healthier and feel better, it caused substantial reductions in death rate."

The participants in the study all had mild lung disease, which itself increases risk for more serious lung disease down the road.

In an editorial, "Smoking Kills, Experimental Proof from the Lung Health Study," Jonathan M. Samet, MD, MS, of the Johns Hopkins Bloomberg School of Public Health, says that the importance of the new findings is that t
'"/>

Contact: Susan Anderson
sanderson@acponline.org
215-351-2653
American College of Physicians
14-Feb-2005


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. UMaine study looks at infants and chronic nighttime crying
3. Chronic pain treatments more effective when taken together, new study shows
4. UNC study: Most N.C. family practitioners engage in unrecognized community service
5. New study in Nature demonstrates protection against cell death during heart attack
6. UCSF study offers insight into human circadian rhythms
7. International breast cancer prevention study launches in the United States and Canada
8. UW study shows blacks and Latinos are more satisfied with physicians of the same race
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. Advertising by academic medical centers may risk eroding public trust, says study
11. Fat may promote inflammation, new study suggests

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: year study finds that quitting smoking adds years life

(Date:5/20/2013)... CA (PRWEB) May 20, 2013 ... in adult allogeneic stem cell manufacturing, research and ... Professor of Medicine and Director of Interventional Cardiology ... to join the Scientific and Medical Advisory Board ... University of Pennsylvania, Dr. Wilensky divides his time ...
(Date:5/20/2013)... proud to announce the publication of the much-anticipated Second ... Weinberg. , The First Edition has been hailed ... most important advances in the fast-growing field of cancer ... of its hallmark features admired by students, instructors, researchers, ... Cancer is a textbook for students studying the molecular ...
(Date:5/20/2013)... , , MONDAY, May 20 (HealthDay News) -- Boys who ... as likely to become obese adults as those who ... new 30-year study shows. Researchers found that men ... index (BMI) and obesity, even if they no longer ... well-off or poor, they tended toward obesity. ...
(Date:5/20/2013)... 2013 In celebration of National Women’s ... accomplishments achieved at The Feinstein Institute for Medical ... Advancing Women in Science and Medicine (AWSM) , ... Scientists, educators, business and community leaders from the ... of women in science. , “Women face unique ...
(Date:5/20/2013)... high schoolers prepare for final exams, teens nationwide may ... prescription stimulant or amphetamine -- to gain an academic ... only one in 100 parents of teens 13-17 years ... drug., Study drugs refer to stimulant medications typically prescribed ... commonly prescribed medicines in this category include Adderall, Concerta, ...
Breaking Medicine News(10 mins):Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3Health News:'The Biology of Cancer' by Robert A. Weinberg 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3Health News:1 in 10 teens using 'study drugs,' but parents aren't paying attention 2
(Date:5/19/2013)... May 20, 2013  Whole-cell pertussis vaccines were more ... during a large recent outbreak, according to a new ... pertussis vaccines, also called DTwP, were available from the ... that ultimately led to the development of acellular pertussis ... 1990s, the United States had ...
(Date:5/18/2013)... 2013 Faruqi & Faruqi, LLP, a ... securities fraud at AVEO Pharmaceuticals, Inc. ("AVEO" or ... http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) The investigation focuses ... federal securities laws by issuing materially false and/or ... trials for Tivopath (tivozanib) (titled "TIVO-1").  Specifically, the ...
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
Breaking Medicine Technology:Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
Cached News: